Anhydrous Lactose Market Report 2026

The anhydrous lactose market size has grown strongly in recent years. It will grow from $1.24 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to growth of solid oral dosage manufacturing, expansion of generic drug production, increased use of lactose-based excipients, rising pharmaceutical manufacturing capacity, standardization of excipient quality requirements.

The anhydrous lactose market size is expected to see strong growth in the next few years. It will grow to $1.64 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for high-stability excipients, expansion of biopharmaceutical production, rising focus on advanced drug formulation techniques, growth in contract manufacturing organizations, increasing regulatory emphasis on excipient traceability. Major trends in the forecast period include increasing use of anhydrous lactose in moisture-sensitive drug formulations, rising demand for direct compression grade lactose, growing focus on improved powder flow properties, expansion of pharmaceutical-grade excipient applications, enhanced quality control in lactose manufacturing.

The rise in pharmaceutical drug production is expected to drive the growth of the anhydrous lactose market going forward. Pharmaceutical drug production entails the systematic manufacturing of medicines under stringent controls to ensure their safety, efficacy, and quality for medical use. The increase in pharmaceutical drug production is fueled by the growing aging population, which drives higher demand for advanced treatments to manage chronic diseases effectively. Anhydrous lactose serves as a versatile excipient in pharmaceutical drug production, mainly functioning as a filler and binder. Its moisture-free properties enhance the stability and shelf life of tablets and capsules, ensuring consistent drug delivery and quality. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe reached €390.0 billion ($422,803 million) in 2023, up from €363.3 billion ($393,857 million) in 2022. Therefore, the rising pharmaceutical drug production is driving the growth of the anhydrous lactose market.

Key companies in the anhydrous lactose market are focusing on developing innovative products such as pharmaceutical-grade lactose for oral solid dose (OSD) applications to meet the growing demand from tablet and capsule manufacturing. Pharmaceutical-grade lactose is highly purified and produced according to strict pharmacopeial standards (such as USP and Ph. Eur.), unlike edible-grade lactose, which does not meet the regulatory, purity, or particle-size requirements for pharmaceuticals. For instance, in October 2023, Lactalis Ingredients, a France-based dairy-ingredient company, launched its Lactalis Ingredients Pharma business line and introduced the Lactalpha range of milled and sieved pharmaceutical-grade lactose monohydrate (50, 100, 150 mesh). Lactalpha lactose ensures reliable flow, compactibility, and consistency in tablet and capsule production. This expansion into the pharmaceutical lactose market reflects the trend of dairy-ingredient manufacturers moving into high-value pharma excipients to supply stable, compliant, and high-performance materials.

In April 2025, LBB Specialties, a US-based specialty chemicals and ingredient distributor, partnered with Kerry Group to expand access and enhance excellence in pharmaceutical solutions. The partnership aims to increase access to Kerry’s premium Sheffield brand pharmaceutical-grade lactose excipients across the U.S., improving product consistency, supply chain efficiency, and innovation in life sciences formulations. Kerry Group is an Ireland-based manufacturer of pharmaceutical-grade lactose excipients.

Major companies operating in the anhydrous lactose market are Kerry Group, Sigma-Aldrich, Fagron Group, Spectrum Chemical Mfg. Corp., DFE Pharma, Wako Pure Chemical Industries Ltd., Anshul Life Sciences, Salius Pharma Pvt. Ltd., SimSon Pharma Limited, MEGGLE GmbH & Co. KG, VIVAN Life Science, Aurora Industry Co. Ltd, Glentham Life Sciences Limited, Lactalis Ingredients, Colorchem Industries Ltd., Jiangsu Dawning Pharmaceutical Co. Ltd., International Ingredients & Excipients Pvt. Ltd., Fengchen Group Co. Ltd, Xi'an Harmonious Natural Biotechnology Co. Ltd., Hexon Laboratories Private Limited.

North America was the largest region in the anhydrous lactose market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anhydrous lactose market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anhydrous lactose market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the anhydrous lactose market by increasing costs of imported dairy raw materials, processing equipment, and pharmaceutical-grade purification systems used in lactose production. Pharmaceutical and food manufacturers in North America and Europe are most affected due to reliance on cross-border dairy supply chains, while Asia-Pacific faces cost pressure on imported high-purity lactose grades. These tariffs are raising production costs and influencing pricing strategies. However, they are also encouraging domestic lactose processing, regional sourcing of dairy inputs, and investments in localized pharmaceutical excipient manufacturing capabilities.

The anhydrous lactose market research report is one of a series of new reports that provides anhydrous lactose market statistics, including anhydrous lactose industry global market size, regional shares, competitors with a anhydrous lactose market share, detailed anhydrous lactose market segments, market trends and opportunities, and any further data you may need to thrive in the anhydrous lactose industry. This anhydrous lactose market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anhydrous lactose is a purified, low-moisture form of lactose that does not absorb water, making it highly suitable for pharmaceutical applications. It is commonly used as a filler or diluent in tablets and capsules to ensure uniform dosing and improve tablet strength. Its stability makes it ideal for moisture-sensitive formulations and enhances powder flow during manufacturing.

The primary product types of anhydrous lactose are edible lactose, pharmaceutical lactose, and technical lactose. Edible anhydrous lactose is a food-grade, moisture-free milk sugar used as a stable, mild sweetener in bakery, confectionery, and dairy products, helping preserve texture and quality in dry food applications. It is available in various forms, including powder, granules, and tablets, and is distributed through channels such as online retail, supermarkets or hypermarkets, specialty stores, and pharmacies. It is applied in areas such as pharmaceutical excipients, lyophilized products, baby food formulas, and others, and is used by end users including the food industry, pharmaceutical industry, animal feed industry, cosmetic industry, and others.

The anhydrous lactose market consists of sales of anhydrous alpha-lactose and anhydrous beta-lactose. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.